What We Do
We fight to change economic policy and narratives in order to build public power, break up concentrations of private power, and deliver true opportunity and prosperity for all.
Watch VideoWe fight to change economic policy and narratives in order to build public power, break up concentrations of private power, and deliver true opportunity and prosperity for all.
Watch VideoAmericans pay more for prescription drugs than patients in any other wealthy country, and it's not just due to exorbitant pricing by drug manufacturers. Three corporate middlemen — CVS Caremark, Express Scripts, and OptumRx — control key channels in the drug supply chain, including roughly 80% of prescription claims in the U.S. Their business model artificially inflates and benefits from high drug prices. Government regulation and enforcement is not enough.
The U.S. pharmaceutical industry is a highly profitable, highly extractive industry. While it delivers scientific breakthroughs and develops life-saving treatments for illnesses that were once incurable, the industry fails Americans on numerous fronts. We lack a business model that can discipline or provide an alternative to the price gouging rampant in both branded and generic drug markets. In this brief, we propose a solution: AmericaRx.
From health care to travel to energy, Trump’s corrupt wheelings and dealings have drained money from American families.
As Trump’s war in Iran sends gas prices soaring, major oil companies are cashing in.
As Americans kick off the summer this Memorial Day weekend, Trump’s mishandling of the economy will leave families paying much more to enjoy the warmer season.
As extreme heat intensifies, the cost of inaction will be measured in lives lost. The question facing policymakers is no longer whether effective protections exist, but whether they have the political will to stand up to those unscrupulous employers lobbying hard to block them.
Nearly a year after Trump signed the One Big Beautiful Bill, families are paying more, earning less, and losing the benefits they depend on.
Trump’s erratic tariff policies served as a vehicle for corporate corruption and grift, paid for by workers and families.
President Trump promised to cut energy prices in half within his first year in office. He has done the exact opposite.
In this brief, we dissect the housing affordability debate, zeroing in on financing conditions that have largely been missing. We lay out the fundamentals of housing economics, survey the current policy landscape, and explain how popular proposals to loosen regulations may not lower housing costs on their own. And we outline the federal policy levers that would actually make housing more affordable.